https://www.selleckchem.com/products/Nolvadex.html
The aim of this work was to evaluate changes in glycaemic control (HbA ) and rates of severe hypoglycaemia over a 2year period after initiation of flash glucose monitoring (FM) in type 1 diabetes. Using data from the Swedish National Diabetes Registry, 14,372 adults with type 1 diabetes with a new registration of FM during 2016-2017 and with continued FM for two consecutive years thereafter, and 7691 control individuals using conventional self-monitoring of blood glucose (SMBG) during the same observation period, were included in a coh